October 1, 2025

Highlighting Recent Findings on Icotrokinra, Other Psoriasis Developments, with Mark Lebwohl, MD – HCPLive

September 30, 2025

Excimer Laser Plus Tacrolimus Shows Superior Psoriasis Results – Dermatology Times

September 30, 2025

J&J gets FDA approval for Tremfya in paediatric psoriasis – Pharmaceutical Technology

September 30, 2025

U.S. FDA approves TREMFYA® (guselkumab) for the treatment of pediatric plaque psoriasis and active psoriatic arthritis, marking a first and only approval for an IL-23 inhibitor – BioSpace

September 30, 2025

J&J’s Tremfya secures two paediatric psoriasis approvals from FDA – European Pharmaceutical Review